Amphetamine stereotypy, the basal ganglia, and the " selection problem"

Behavioural Brain Research

Volumn 231, Issue 2, 2012, Pages 297-308

  Wolgin, David L ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Amphetamine; Basal ganglia; Contingent tolerance; Response selection suppression; Stereotypy; Tourette's syndrome

Indexed keywords

AMPHETAMINE; CATHINONE; COCAINE; MESSENGER RNA; PROTEIN C FOS;

ANOREXIA; BASAL GANGLION; BRAIN REGION; CORPUS STRIATUM; DECISION MAKING; DRUG DEPENDENCE; FEEDING BEHAVIOR; FOOD INTAKE; GILLES DE LA TOURETTE SYNDROME; HEAD MOVEMENT; LEARNING; LICKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REINFORCEMENT; REVIEW; STEREOTYPY; STIMULUS RESPONSE;

AMPHETAMINE; ANIMALS; ANOREXIA; APPETITIVE BEHAVIOR; BASAL GANGLIA; CENTRAL NERVOUS SYSTEM STIMULANTS; CONSUMMATORY BEHAVIOR; DRUG TOLERANCE; FEEDING BEHAVIOR; LEARNING; RATS; STEREOTYPED BEHAVIOR;

EID: 84860839552     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.003     Document Type: Review

References (118)

1. Golani I., Wolgin D.L., Teitelbaum P. A proposed natural geometry of recovery from akinesia in the lateral hypothalamic rat. Brain Res 1979, 164:237-267.
2. Teitelbaum P., Pellis S.M., DeVietti T. Disintegration into stereotypy induced by drugs or brain damage: a microdescriptive behavioural analysis. Neurobiology of stereotyped behaviour 1990, 169-199. Clarendon Press, Oxford. S.J. Cooper, C.T. Dourish (Eds.).
3. Teitelbaum P. Physiological psychology 1967, Prentice Hall, Englewood Cliffs, NJ.
4. Wolgin D.L., Salisbury J.J. Amphetamine tolerance and body weight set point: a dose-response analysis. Behav Neurosci 1985, 99:175-185.
5. Hughes K.M., Popi L., Wolgin D.L. Experiential constraints on the development of tolerance to amphetamine hypophagia following sensitization of stereotypy: instrumental contingencies regulate the expression of sensitization. Psychopharmacology (Berl) 1998, 140:445-449.
6. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 1986, 11:157-198.
7. Segal D.S., Mandell A.J. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 1974, 2:249-255.
8. Wolgin D.L., Kinney G.G. Effect of prior sensitization of stereotypy on the development of tolerance to amphetamine-induced hypophagia. J Pharmacol Exp Ther 1992, 262:1232-1241.
9. Volkow N., Li T-K. The neuroscience of addiction. Nat Neurosci 2005, 8:1429-1430.
10. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004, 47:33-46.
11. Wolgin D.L. Contingent tolerance to amphetamine hypophagia: new insights into the role of environmental context in the expression of stereotypy. Neurosci Biobehav Rev 2000, 24:279-294.
12. Carlton P.L., Wolgin D. Contingent tolerance to the anorexigenic effects of amphetamine. Physiol Behav 1971, 7:221-223.
13. Woolverton W.L., Kandel D., Schuster C.R. Tolerance and cross-tolerance to cocaine and d-amphetamine. J Pharmacol Exp Ther 1978, 205:525-535.
14. Emmett-Oglesby M.W., Taylor K.E. Role of dose interval in the acquisition of tolerance to methylphenidate. Neuropharmacology 1981, 20:995-1002.
15. Foltin R.W., Schuster C.R. Behavioral tolerance and cross-tolerance to dl-cathinone and d-amphetamine in rats. J Pharmacol Exp Ther 1982, 222:126-131.
16. Corfield-Sumner P.K., Stolerman I.P. Behavioral tolerance. Contemporary research in behavioural pharmacology 1978, 391-448. Plenum Press, New York. D.E. Blackman, D.J. Sanger (Eds.).
17. Schuster C.R., Dockens W.S., Woods J.H. Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacologia 1966, 9:170-182.
18. Demellweek C., Goudie A.J. Behavioural tolerance to amphetamine and other psychostimulants: the case for considering behavioural mechanisms. Psychopharmacology (Berl) 1983, 80:287-307.
19. Salisbury J.J., Wolgin D.L. Role of anorexia and behavioral activation in amphetamine-induced suppression of feeding: implications for understanding tolerance. Behav Neurosci 1985, 99:1153-1161.
20. Wolgin D.L., Hertz J.M. Effects of acute and chronic cocaine on milk intake, body weight, and activity in bottle- and cannula-fed rats. Behav Pharmacol 1995, 6:746-753.
21. Wolgin D.L., Munoz J.R. Role of instrumental learning in tolerance to cathinone hypophagia. Behav Neurosci 2006, 120:362-370.
22. Grill H.J., Norgren R. The taste reactivity test: I. Mimetic responses to gustatory stimuli in neurologically normal rats. Brain Res 1978, 143:263-279.
23. Wolgin D.L., Thompson G.B., Oslan I.A. Tolerance to amphetamine: contingent suppression of stereotypy mediates recovery of feeding. Behav Neurosci 1987, 101:264-271.
24. Wolgin D.L., Hughes K.M. Effect of sensitization of stereotypy on the acquisition and retention of tolerance to amphetamine hypophagia. Psychopharmacology (Berl) 1996, 126:219-225.
25. Wolgin D.L., Hughes K.M. Long term retention of tolerance to amphetamine hypophagia following cessation of drug injections and feeding tests. Pharmacol Biochem Behav 2001, 70:367-373.
26. Hughes K.M., Wolgin D.L. Changes in behavioural contingencies produce a loss of tolerance to amphetamine hypophagia in rats despite continued feeding tests while drugged. Behav Pharmacol 2002, 13:279-286.
27. Wolgin D.L., Wade J.V. Learned suppression of stereotypy in amphetamine-treated rats: implications for understanding tolerance to amphetamine 'anorexia'. Behav Pharmacol 1995, 6:254-262.
28. Hughes K.M., Popi L., Wolgin D.L. Loss of tolerance to amphetamine-induced hypophagia in rats: homeostatic readjustment vs. instrumental learning. Pharmacol Biochem Behav 1999, 64:177-182.
29. Poulos C.X., Wilkinson D.A., Cappell H. Homeostatic regulation and Pavlovian conditioning in tolerance to amphetamine-induced anorexia. J Comp Physiol Psychol 1981, 95:735-746.
30. Wolgin D.L., Hughes K.M. Role of behavioral and pharmacological variables in the loss of tolerance to amphetamine hypophagia. Psychopharmacology (Berl) 1997, 132:342-349.
31. Wolgin D.L., Jakubow J.J. Tolerance to amphetamine hypophagia: a real-time depiction of learning to suppress stereotyped movements in the rat. Behav Neurosci 2004, 118:470-478.
32. Wolgin D.L., Jakubow J.J. Tolerance to amphetamine hypophagia: a microstructural analysis of licking behavior in the rat. Behav Neurosci 2003, 117:95-104.
33. Davis J.D. The effectiveness of some sugars in stimulating licking in the rat. Physiol Behav 1973, 11:39-45.
34. Davis J.D. Deterministic and probabilistic control of the behavior of rats ingesting liquid diets. Am J Physiol 1996, 270:R793-R800.
35. Redgrave P., Prescott T.J., Gurney K. The basal ganglia: a vertebrate solution to the selection problem?. Neuroscience 1999, 89:1009-1023.
36. Balleine B.W., O'Doherty J.P. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2010, 35:48-69.
37. Balleine B.W., Liljeholm M., Ostlund S.B. The integrative function of the basal ganglia in instrumental learning. Behav Brain Res 2009, 199:43-52.
38. Graybiel A.M., Canales J.J., Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 2000, 23(Suppl.):S71-S77.
39. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 2004, 27:765-776.
40. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 1996, 50:381-425.
41. Scheel-Kruger J., Magelund J. GABA in the entopeduncular nucleus and the subthalamic nucleus participates in mediating dopaminergic striatal output functions. Life Sci 1981, 29:1555-1562.
42. Scheel-Kruger J., Arnt J., Magelund G. Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra. Neurosci Lett 1977, 4:351-356.
43. Yin H.H., Knowlton B.J. The role of the basal ganglia in habit formation. Nat Rev Neurosci 2006, 7:464-476.
44. Yin H.H., Ostlund S.B., Balleine B.W. Reward-guided learning beyond dopamine in the nucleus accumbens: the integrative functions of cortico-basal ganglia networks. Eur J Neurosci 2008, 28:1437-1448.
45. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986, 9:357-381.
46. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. 1. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 1995, 20:91-127.
47. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Rev 1995, 20:128-154.
48. Haber S.N., Fudge J.L., McFarland N.R. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 2000, 20:2369-2382.
49. Joel D., Weiner I. The organization of the basal ganglia thalamocortical circuits:open interconnected rather than closed segregated. Neuroscience 1994, 63:363-379.
50. Calabresi P., Picconi B., Tozzi A., Di Filippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 2007, 30:211-219.
51. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol 1998, 80:1-27.
52. Wolf M.E., Sun X., Mangiavacchi S., Chao S.Z. Psychomotor stimulants and neuronal plasticity. Neuropharmacology 2004, 47:61-79.
53. Chevalier G., Vacher S., Deniau J.M., Desban M. Disinhibition as a basic process in the expression of striatal functions. I. The striato-nigral influence on tecto-spinal/tecto-diencephalic neurons. Brain Res 1985, 334:215-226.
54. Deniau J.M., Chevalier G. Disinhibition as a basic process in the expression of striatalfunctions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus. Brain Res 1985, 334:227-233.
55. Nambu A. Seven problems on the basal ganglia. Curr Op Neurobiol 2008, 18:595-604.
56. Nambu A., Tokuno H., Takada M. Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neurosci Res 2002, 43:111-117.
57. Grillner S., Hellgren J., Menard A., Saitoh K., Wikstrom M.A. Mechanisms for selection of basic motor programs-roles for the striatum and pallidum. Trends Neurosci 2005, 28:364-370.
58. Mogenson G.J. Limbic-motor integration. Progress in psychobiology and physiological psychology 1987, vol. 12:117-170. Academic Press, New York.
59. Mogenson G.J., Jones D.L., Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 1980, 14:69-97.
60. Nicola S.M. The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology (Berl) 2007, 191:521-550.
61. Creese I., Iversen S.D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 1975, 83:419-436.
62. Price M.T.C., Fibiger H.C. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra. Eur J Pharmacol 1974, 29:249-252.
63. Fibiger H.C., Fibiger H.P., Zis A.P. Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat. Brit J Pharmacol 1973, 47:683-692.
64. Joyce E.M., Iversen S.D. Dissociable effects of 6-OHDA-induced lesions of neostriatum on anorexia, locomotor activity and stereotypy: the role of behavioral competition. Psychopharmacology (Berl) 1984, 83:363-366.
65. Costall B., Marsden C.D., Naylor R.J., Pycock C.J. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei. Brain Res 1977, 123:89-111.
66. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 1975, 94:507-522.
67. Baker D.A., Specio S.E., Tran-Nguyen L.T.L., Neisewander J.L. Amphetamine infused into the ventrolateral striatum produces oral stereotypies and conditioned place preference. Pharmacol Biochem Behav 1998, 61:107-111.
68. Dickson P.R., Lang C.G., Hinton S.C., Kelley A.E. Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience 1994, 61:81-91.
69. Kelley A.E., Lang C.G., Gauthier A.M. Induction of oral stereotypy followingamphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology (Berl) 1988, 95:556-559.
70. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 1990, 87:6912-6916.
71. Canales J.J., Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat Neurosci 2000, 3:377-383.
72. Olianas M.C., DeMontis G.M., Mulas G., Tagliamonte A. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAeric pathway. Eur J Pharm 1978, 49:233-241.
73. Grabli D., McCarin K., Hirsch E.C., Agid Y., Feger J., Francois C., et al. Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain 2004, 19:2039-2054.
74. Francois C., Grabli D., McCairn K., Jan C., Karachi C., Hirsch E-C., et al. Behavioural disorders induced by external globus pallidus dysfunction in primates. II. Anatomical study. Brain 2004, 127:2055-2070.
75. Baup N., Grabli D., Karachi C., Mounayar S., Francois C., Yelnik J., et al. High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates. J Neurosci 2008, 28:8785-8788.
76. Bachus S.E., Gale K. Muscimol microinfused into the nigrotegmental target area blocks selected components of behavior elicited by amphetamine or cocaine. Naunyn-Schmiedeberg's Arch Pharmacol 1986, 333:143-148.
77. Childs J.A., Gale K. Evidence that the nigrotegmental GABAergic projection mediates stereotypy induced by apomorphine and intranigral muscimol. Life Sci 1983, 33:1007-1010.
78. Allen L.F., Winn P. Excitotoxic lesions of the pedunculopontine tegmental nucleus disinhibit orofacial behaviours stimulated by microinjections of d-amphetamine into rat ventrolateral caudate-putamen. Exp Brain Res 1995, 104:262-274.
79. Inglis W.L., Allen L.F., Whitelaw R.B., Latimer M.P., Brace H.M., Winn P. An investigation into the role of the pedunculopontine tegmental nucleus in the mediation of locomotion and orofacial stereotypy induced by d-amphetamine and apomorphine in the rat. Neuroscience 1994, 58:817-833.
80. Miller A.D., Forster G.L., Metcalf K.M., Blaha C.D. Excitotoxic lesions of the pedunculopontine differentially mediate morphine- and d-amphetamine-evoked striatal dopamine efflux and behaviors. Neuroscience 2002, 111:351-362.
81. Dean P., Redgrave P., Eastwood L. Suppression of apomorphine-induced oral stereotypy in rats by microinjection of muscimol into midbrain. Life Sci 1982, 30:2171-2179.
82. Pope S.G., Dean P., Redgrave P. Dissociation of d-amphetamine-induced locomotor activity and stereotyped behaviour by lesions of the superior colliculus. Psychopharmacology (Berl) 1980, 70:297-302.
83. Redgrave P.R., Dean P., Donohoe T.P., Pope S.G. Superior colliculus lesions selectively attenuate apomorphine-induced oral stereotypy: a possible role for the nigrotectal pathway. Brain Res 1980, 196:541-546.
84. Sirkin D.W., Teitelbaum P. The pontine reticular formation is part of the output pathway for amphetamine- and apomorphine-induced lateral head movements: evidence from experimental lesions in the rat. Brain Res 1983, 260:291-296.
85. Bachand K.D., Guthrie K.M., Wolgin D.L. Expression of c-fos mRNA in the basal ganglia associated with contingent tolerance to amphetamine-induced hypophagia. Behav Brain Res 2009, 198:388-396.
86. Curran E.J., Akil H., Watson S.J. Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem Res 1996, 21:1425-1435.
87. Badiani A., Oates M.M., Day H.E.W., Watson S.J., Akil H., Robinson T.E. Amphetamine-induced behavior, dopamine release and c-fos mRNA expression: modulation by environmental novelty. J Neurosci 1998, 18:10579-10593.
88. Badiani A., Oates M.M., Day H.E.W., Watson S.J., Akil H., Robinson T.E. Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res 1999, 103:203-209.
89. Uslaner J., Badiani A., Day H.E.W., Watson S.J., Akil H., Robinson T.E. Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res 2001, 920:106-116.
90. Uslaner J., Badiani A., Norton C.S., Day H.E.W., Watson S.J., Akil H., et al. Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 2001, 13:1977-1983.
91. Uslaner J., Norton C.S., Watson S.J., Akil H., Robinson T.E. Amphetamine-induced c-fos mRNA expression in the caudate-putamen and subthalamic nucleus: interactions between dose, environment, and neuronal phenotype. J Neurochem 2003, 85:105-114.
92. Eagle D.M., Baunez C. Is there an inhibitory-response-control system in the rat?Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 2010, 34:50-72.
93. Inglis W.L., Winn P. The pedunculopontine tegmental nucleus: where the striatum meets the reticular formation. Prog Neurobiol 1995, 47:1-29.
94. Winn P., Brown V.J., Inglis W.L. On the relationships between the striatum and the pedunculopontine tegmental nucleus. Crit Rev Neurobiol 1997, 11:241-261.
95. Humphries M.D., Gurney K., Prescott T.J. Is there a brainstem substrate for action selection?. Philos Trans R Soc B 2007, 362:1627-1639.
96. Burke K., Lombroso P.J. Animal models of Tourette syndrome. Animal models of movement disorders 2005, 441-448. Elsevier Academic Press, Burlington, MA. M. Le Doux (Ed.).
97. Peterson B.S. Neuroimaging studies of Tourette syndrome: a decade of progress. Tourette syndrome 2001, 179-196. Lippincott Williams and Wilkins, Philadelphia. D.J. Cohen, C.G. Goetz, J. Jankovic (Eds.).
98. Mink J.W. Basal ganglia dysfunction in Tourette's syndrom: a new hypothesis. Pediat Neurol 2001, 25:190-198.
99. Mink J.W. Neurobiology of basal ganglia circuits in Tourette syndrome: faulty inhibition of unwanted motor patterns?. Tourette syndrome 2001, 113-122. Lippincott Williams and Wilkins, Philadelphia. D.J. Cohen, C.G. Goetz, J. Jankovic (Eds.).
100. Azrin N.H., Peterson A.L. Treatment of Tourette syndrome by habit reversal: a waiting-list control group comparison. Behav Ther 1990, 21:305-318.
101. Himle M.B., Woods D.W., Piacentini J.C., Walkup J.T. Brief review of habit reversal training for Tourette syndrome. J Child Neurol 2006, 21:719-725.
102. Piacentini J., Woods D.W., Scahell L., Wilhelm S., Peterson A.L., Chang S., et al. Behavior therapy forchildren with Tourette disorder: a randomized controlled trial. JAMA 2010, 303:1929-1937.
103. Wilhelm S., Deckersbach T., Coffey B.J., Bohne A., Peterson A.L., Baer L. Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiatry 2003, 160:1175-1177.
104. Piacentini J., Chang S. Behavioral treatments for Tourette syndrome and tic disorders: state of the art. Tourette syndrome 2001, 319-331. Lippincott Williams and Wilkins, Philadelphia. D.J. Cohen, C.G. Goetz, J. Jankovic (Eds.).
105. Robinson T.E., Berridge K.C. Addict Ann Rev Psychol 2003, 54:25-53.
106. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002, 159:1642-1652.
107. Jentsch J.D., Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999, 146:373-390.
108. Fillmore M.T., Rush C.R. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend 2002, 66:265-273.
109. Fillmore M.T., Rush D.R., Marczinski C.A. Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 2003, 71:143-152.
110. Ray Li C.-S., Sinha R. Inhibitory control and emotional stress regulation: neuroimaging evience for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci Biobehav Rev 2008, 32:581-597.
111. Monterosso J.R., Aron A.R., Cordova X., Xu J., London E.D. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005, 79:273-277.
112. Feil J., Sheppard D., Fitzgerald P.B., Yucel M., Lubman D.I., Bradshaw J.L. Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev 2010, 35:248-275.
113. Volkow N.D., Fowler J.S., Wang G-J., Telang F., Logan J., Jayne M., et al. Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage 2010, 49:2536-2543.
114. Bigelow G.E., Brooner R.K., Silverman K. Competing motivations: drug reinforcement vs. non-drug reinforcement. J Psychopharmacol 1998, 12:8-14.
115. Higgins S.T., Delaney D.D., Budney A.J., Bickel W.K., Hughes J.R., Foerg F., et al. A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry 1991, 148:1218-1224.
116. Higgins S.T., Budney A.J., Bickel W.K., Hughes J.R., Foerg F., Badger G.J. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 1993, 150:763-769.
117. Higgins S.T., Budney A.J., Bickel W.K. Applying behavioral concepts and principles to the treatment of cocaine dependence. Drug Alcohol Depend 1994, 34:87-97.
118. Roll J.M., Petry N.M., Stitzer M.L., Brecht M.L., Peirce J.M., McCann M.J., et al. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 2006, 163:1993-1999.